Francesca Barone, M.D.
Ph.D. Chief Scientific OfficeratCandel Therapeutics· In proxies 2022–2025
Francesca Barone, M.D. is Ph.D. Chief Scientific Officer of Candel Therapeutics.
Experience
- Candel TherapeuticsPublic company · 4 yr
- Ph.D. Chief Scientific Officer2022 – Present · 4 yrStock in role +11%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?